focus -WSS

focus

author：knowledge 2025-09-05 03:01:18 - browse：78183

King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT — Pat Greenhouse/Globe Staff

MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Covid hospitalizations on the rise, Humana says

hotspot

WSS

How to fix cancer clinical trials' diversity problem

A new House health package & hospitals’ new site

The Readout: Lenmeldy, GLP

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

focus

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

A new House health package & hospitals’ new site

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Supreme Court mifepristone arguments center on docs' right to sue

Virginia high school admissions case could be legal follow

Covid vaccine financial winners and losers, from Pfizer to Novavax

Bright Health sells Medicare Advantage business to Molina

Weighted lottery helped low

Cancer drug shortages should be causing more outrage

Will generative AI in health care meet the fate of IBM's Dr. Watson?

focus

Amazon on where the company's health care bets are headed next

Stem cell treatment guidelines are released by FDA

Vertex Pharmaceuticals may move headquarters in Boston

Abortion pill Supreme Court ruling could impact entire drug industry

Readout LOUD podcast: mifepristone case, GLP

Ethical issues complicate the benefits of medical crowdfunding

entertainment

hotspot

hotspot

explore